Modra

A novel oral approach to improve the convenience and therapeutic index of chemotherapy in the treatment of cancer

Switching from intravenous (IV)-to-oral treatment reduces side effects, improves patient convenience and allows options for modern combinatorial cancer treatment regimens

Learn more

News

Modra Pharmaceuticals Expands Management Team and Provides Corporate Update
Read more

the IV to Oral switch

improving patient lives
Learn more

Events

Meet us at one of the following events:      
Read more